TLX controls angiogenesis through interaction with the von Hippel-Lindau protein

Biology Open

Volumn 1, Issue 6, 2012, Pages 527-535

  Zeng, Zhao Jun ^a,b   Johansson, Erik ^a   Hayashi, Amiko ^a   Chavali, Pavithra L ^a   Akrap, Nina ^a   Yoshida, Takeshi ^a,c   Kohno, Kimitoshi ^c   Izumi, Hiroto ^c   Funa, Keiko ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Angiogenesis; HIF 2 ; Neuroblastoma; TLX; VHL

Indexed keywords

EID: 84964811353     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.2012893     Document Type: Article

References (33)

1. Bunn, H. F., Gu, J., Huang, L. E., Park, J. W. and Zhu, H. (1998). Erythropoietin: a model system for studying oxygen-dependent gene regulation. J. Exp. Biol. 201, 1197-1201.
2. Cai, Q. and Robertson, E. S. (2010). Ubiquitin/SUMO modification regulates VHL protein stability and nucleocytoplasmic localization. PLoS ONE 5, e12636.
3. Cai, Q., Verma, S. C., Kumar, P., Ma, M. and Robertson, E. S. (2010). Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification. PLoS ONE 5, e9720.
4. Chavali, P. L., Saini, R. K., Matsumoto, Y., Ågren, H. and Funa, K. (2011). Nuclear orphan receptor TLX induces Oct-3/4 for the survival and maintenance of adult hippocampal progenitors upon hypoxia. J. Biol. Chem. 286, 9393-9404.
5. Covello, K. L., Simon, M. C. and Keith, B. (2005). Targeted replacement of hypoxiainducible factor-1alpha by a hypoxia-inducible factor-2alpha knock-in allele promotes tumor growth. Cancer Res. 65, 2277-2286.
6. Hergovich, A., Lisztwan, J., Barry, R., Ballschmieter, P. and Krek, W. (2003). Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat. Cell Biol. 5, 64-70.
7. Hergovich, A., Lisztwan, J., Thoma, C. R., Wirbelauer, C., Barry, R. E. and Krek, W. (2006). Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3. Mol. Cell. Biol. 26, 5784-5796.
8. Holmquist-Mengelbier, L., Fredlund, E., Löfstedt, T., Noguera, R., Navarro, S., Nilsson, H., Pietras, A., Vallon-Christersson, J., Borg, A., Gradin, K. et al. (2006). Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10, 413-423.
9. Iliopoulos, O., Kibel, A., Gray, S. and Kaelin, W. G., Jr. (1995). Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med. 1, 822-826.
10. Izumi, H., Molander, C., Penn, L. Z., Ishisaki, A., Kohno, K. and Funa, K. (2001). Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor. J. Cell Sci. 114, 1533-1544.
11. Kaelin, W. G., Jr. (2007a). Von Hippel-Lindau disease. Annu. Rev. Pathol. 2, 145-173.
12. Kaelin, W. G., Jr. (2007b). The von hippel-lindau tumor suppressor protein: an update. Methods Enzymol. 435, 371-383.
13. Kashiwagi, E., Izumi, H., Yasuniwa, Y., Baba, R., Doi, Y., Kidani, A., Arao, T., Nishio, K., Naito, S. and Kohno, K. (2011). Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines. Cancer Sci. 102, 382-386.
14. Koch, S., Tugues, S., Li, X., Gualandi, L. and Claesson-Welsh, L. (2011). Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 437, 169-183.
15. Kondo, K., Klco, J., Nakamura, E., Lechpammer, M. and Kaelin, W. G., Jr. (2002). Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 1, 237-246.
16. Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E. et al. (2009). Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15, 501-513.
17. Min, J. H., Yang, H., Ivan, M., Gertler, F., Kaelin, W. G. and Jr and Pavletich, N. P. (2002). Structure of an HIF-1alpha-pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886-1889.
18. Miyawaki, T., Uemura, A., Dezawa, M., Yu, R. T., Ide, C., Nishikawa, S., Honda, Y., Tanabe, Y. and Tanabe, T. (2004). Tlx, an orphan nuclear receptor, regulates cell numbers and astrocyte development in the developing retina. J. Neurosci. 24, 8124-8134.
19. Mottet, D., Dumont, V., Deccache, Y., Demazy, C., Ninane, N., Raes, M. and Michiels, C. (2003). Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells. J. Biol. Chem. 278, 31277-31285.
20. Murata, H., Tajima, N., Nagashima, Y., Yao, M., Baba, M., Goto, M., Kawamoto, S., Yamamoto, I., Okuda, K. and Kanno, H. (2002). Von Hippel-Lindau tumor suppressor protein transforms human neuroblastoma cells into functional neuron-like cells. Cancer Res. 62, 7004-7011.
21. Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V. and Kaelin, W. G. (2000). Ubiquitination of hypoxiainducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2, 423-427.
22. Pietras, A., Gisselsson, D., Ora, I., Noguera, R., Beckman, S., Navarro, S. and Påhlman, S. (2008). High levels of HIF-2alpha highlight an immature neural crestlike neuroblastoma cell cohort located in a perivascular niche. J. Pathol. 214, 482-488.
23. Qing, G. and Simon, M. C. (2009). Hypoxia inducible factor-2alpha: a critical mediator of aggressive tumor phenotypes. Curr. Opin. Genet. Dev. 19, 60-66.
24. Qu, Q., Sun, G., Li, W., Yang, S., Ye, P., Zhao, C., Yu, R. T., Gage, F. H., Evans, R. M. and Shi, Y. (2010). Orphan nuclear receptor TLX activates Wnt/β-catenin signalling to stimulate neural stem cell proliferation and self-renewal. Nat. Cell Biol. 12, 31-40.
25. Ryuto, M., Ono, M., Izumi, H., Yoshida, S., Weich, H. A., Kohno, K. and Kuwano, M. (1996). Induction of vascular endothelial growth factor by tumor necrosis factor a in human glioma cells. Possible roles of SP-1. J. Biol. Chem. 271, 28220-28228.
26. Shen, Q., Wang, Y., Kokovay, E., Lin, G., Chuang, S. M., Goderie, S. K., Roysam, B. and Temple, S. (2008). Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. Cell Stem Cell 3, 289-300.
27. Shi, Y., Chichung Lie, D., Taupin, P., Nakashima, K., Ray, J., Yu, R. T., Gage, F. H. and Evans, R. M. (2004). Expression and function of orphan nuclear receptor TLX in adult neural stem cells. Nature 427, 78-83.
28. Shiota, M., Izumi, H., Miyamoto, N., Onitsuka, T., Kashiwagi, E., Kidani, A., Hirano, G., Takahashi, M., Ono, M., Kuwano, M. et al. (2008). Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high-mobility group protein B1. Cancer Sci. 99, 1950-1959.
29. Uemura, A., Kusuhara, S., Wiegand, S. J., Yu, R. T. and Nishikawa, S. (2006). Tlx acts as a proangiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes. J. Clin. Invest. 116, 369-377.
30. Uramoto, H., Izumi, H., Ise, T., Tada, M., Uchiumi, T., Kuwano, M., Yasumoto, K., Funa, K. and Kohno, K. (2002). p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression. J. Biol. Chem. 277, 31694-31702.
31. Wetterskog, D., Moshiri, A., Ozaki, T., Uramoto, H., Nakagawara, A. and Funa, K. (2009). Dysregulation of platelet-derived growth factor beta-receptor expression by DeltaNp73 in neuroblastoma. Mol. Cancer Res. 7, 2031-2039.
32. Wiesener, M. S., Münchenhagen, P. M., Berger, I., Morgan, N. V., Roigas, J., Schwiertz, A., Jürgensen, J. S., Gruber, G., Maxwell, P. H., Löning, S. A. et al. (2001). Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Cancer Res. 61, 5215-5222.
33. Yu, R. T., Chiang, M. Y., Tanabe, T., Kobayashi, M., Yasuda, K., Evans, R. M. and Umesono, K. (2000). The orphan nuclear receptor Tlx regulates Pax2 and is essential for vision. Proc. Natl. Acad. Sci. USA 97, 2621-2625.